Analyst Ratings for Teva Pharma (TEVA)
TEVA Rating Summary
TEVA Price Target Summary
- Highest: $45.00 (Goldman Sachs)
- Lowest: $40.00 (Barclays)
- Average: $41.56
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$41.56 (+32%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$41.56 (+32%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays » Updated 5/6/2026 |
Glen Santangelo | New Coverage | Overweight (N/A) |
40.00 (38.00) |
28.46 (31.48) |
10.61% | Details |
| 12/5/2025 | Scotiabank » Updated 1/29/2026 |
Louise Chen | New Coverage | Sector Outperform (N/A) |
40.00 (35.00) |
27.83 (31.48) |
13.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
